What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Stock Thread (34 Viewers)

-OZ- said:
A few pages back some of you were talking about how many individual stocks you own, some seemed like a lot. What's the general consensus? 

Just looking at my own, I have 8 individual companies, 4 sector funds (QCLN, JETS, SBIO, FIVG), 12 "diversified" ETFs like vug or bnd, then VTI and L2050. 

Curious to get some thoughts here. (Real retirement sometime around 2037-2040 depending on kids and the job at the time)

Not including things at less than 1%: 

L2050 29%
S Fund 14%
C Fund 9%
VUG 5%
VTI 5%
VNQ 4%
BRK-B 4%
VEA 3%
VPU 3%
VBK 3%
VIOO 3%
VTV 3%
VWO 3%
I Fund 2%
OHI 2%
JETS 2%
HD 2%
BABA 1%
DFS 1%
VSS 1%
SBIO 1%
FIVG 1%
QCLN 1%
Click to expand...
FYI - I think this looks very reasonable.  I use a lot of VTI/VUG/VEA/VWO as core holdings for my clients.  I have said before, I think only a portfolio of VTI and BND would work great.  Adding tactical individual plays is great if you have the time.

 
CytoDyn to hold conf call on Monday, April 27

Nader Pourhassan, Ph.D., President and Chief Executive Officer, along with Drs. Bruce Patterson, M.D. and Jacob Lalezari, M.D. will host an investment community conference call on Monday, April 27, 2020 to provide a comprehensive update on several recent developments.

Management will dedicate approximately 45 minutes to address questions from analysts and investors.

Date:Monday, April 27, 2020

Time:10:00 a.m. PT / 1:00 p.m. ET

Dial-In:877-407-2986 US / 201-378-4916 International
Click to expand...

 
-OZ- said:
A few pages back some of you were talking about how many individual stocks you own, some seemed like a lot. What's the general consensus? 

Just looking at my own, I have 8 individual companies, 4 sector funds (QCLN, JETS, SBIO, FIVG), 12 "diversified" ETFs like vug or bnd, then VTI and L2050. 

Curious to get some thoughts here. (Real retirement sometime around 2037-2040 depending on kids and the job at the time)

Not including things at less than 1%: 

L2050 29%
S Fund 14%
C Fund 9%
VUG 5%
VTI 5%
VNQ 4%
BRK-B 4%
VEA 3%
VPU 3%
VBK 3%
VIOO 3%
VTV 3%
VWO 3%
I Fund 2%
OHI 2%
JETS 2%
HD 2%
BABA 1%
DFS 1%
VSS 1%
SBIO 1%
FIVG 1%
QCLN 1%
Click to expand...
Not a fan of the brk-b. It’s been underperforming. Has it gotten too big to be effectively managed?

 
BassNBrew said:
Not a fan of the brk-b. It’s been underperforming. Has it gotten too big to be effectively managed?
Click to expand...
I may sell it in the coming weeks, maybe a swap for Disney if they hit the 80s. Or maybe just trade it for more VTI. 

only bought it thinking WB had the cash on hand to make some big moves. It's been underperforming because he's been sitting on cash. As it is, it's almost equal to holding non dividend paying bonds.

 
-OZ- said:
A few pages back some of you were talking about how many individual stocks you own, some seemed like a lot. What's the general consensus? 

Just looking at my own, I have 8 individual companies, 4 sector funds (QCLN, JETS, SBIO, FIVG), 12 "diversified" ETFs like vug or bnd, then VTI and L2050. 

Curious to get some thoughts here. (Real retirement sometime around 2037-2040 depending on kids and the job at the time)

Not including things at less than 1%: 

L2050 29%
S Fund 14%
C Fund 9%
VUG 5%
VTI 5%
VNQ 4%
BRK-B 4%
VEA 3%
VPU 3%
VBK 3%
VIOO 3%
VTV 3%
VWO 3%
I Fund 2%
OHI 2%
JETS 2%
HD 2%
BABA 1%
DFS 1%
VSS 1%
SBIO 1%
FIVG 1%
QCLN 1%
Click to expand...
Tough love here.  To me, it looks like a list of names that you've collected rather than a portfolio you've curated.  What sectors are you over/under exposed to?  Why?  Under what circumstances will this account over/under perform?  What benchmark are you trying to outperform?

 
chet said:
Tough love here.  To me, it looks like a list of names that you've collected rather than a portfolio you've curated.  What sectors are you over/under exposed to?  Why?  Under what circumstances will this account over/under perform?  What benchmark are you trying to outperform?
Click to expand...
Looks like it’s missing a must own stock too

 
BassNBrew said:
Not a fan of the brk-b. It’s been underperforming. Has it gotten too big to be effectively managed?
Click to expand...
I mean he’s been too big to really generate Alpha. I don’t know what the mark to market is. Obviously some recent investments have been duds but I’m in it for his cash. It’s like buying a less levered private equity company but he gets access to investments we never will. I assume they’re constantly seeing double digit IRR investment opportunities especially now. So hoping he takes advantage of the market. 
 

That and I want to go to Omaha for a shareholders meeting so in it for a bit. 
 

ETA: I guess I should say the alpha I was referring to was meant to be the size and diversification of his investments. I view it as akin to owning an active mutual fund from a diversification standpoint but you get alpha from those investments only he gets. 

 
Last edited by a moderator:
The Lost One said:
Anyone buying DraftKings (DKNG)?
Click to expand...
I got a little at $19.95.  If I remember correctly, the only two other IPOs I've ever bought were FB & BABA.  I bought them the day of the IPO, they went down like 50%, and once they got back to what I originally paid I bailed, just happy to get my $ back.  In hindsight, not very smart investing.  I have to mentally prepare myself for that scenario again, but I'm not sure if that's typical of IPOs?  People get excited to buy it the day it opens and the investors cash in, sending it down temporarily?

 
chet said:
Tough love here.  To me, it looks like a list of names that you've collected rather than a portfolio you've curated.  What sectors are you over/under exposed to?  Why?  Under what circumstances will this account over/under perform?  What benchmark are you trying to outperform?
Click to expand...
I'll reply in more detail later, but this is across 9 accounts. College, tsp, Roth IRAs.  Two accounts use the Paul Merriman approach, another is a collection of assets I think will do well going forward.  You don't see bonds on here because my pension is (IMO anyway) equivalent to a bond.

 
Last edited by a moderator:
chet said:
Tough love here.  To me, it looks like a list of names that you've collected rather than a portfolio you've curated.  What sectors are you over/under exposed to?  Why?  Under what circumstances will this account over/under perform?  What benchmark are you trying to outperform?
Click to expand...
I understand what you are saying but this portfolio is better set up than 95% of the folks that I initially meet with.  I would recommend adding tech as I continue to like it and you don't have enough exposure, VGT is great.  

 
BassNBrew said:
Sold my uuuu this morning for a 3.5% loss.     
Click to expand...
Still holding half.  Had a sell order in than decided to wait until their 11:30 webcast today.  Guess I didn't learn from yesterday's.  What's the saying, "fool me once, DOUBLE DOWN!"  

 
Don't Noonan said:
I understand what you are saying but this portfolio is better set up than 95% of the folks that I initially meet with.  I would recommend adding tech as I continue to like it and you don't have enough exposure, VGT is great.  
Click to expand...
Would you consider FIVG to be too limited with regards to tech? The top holdings don't overlap but the sectors seem to.

 
-OZ- said:
Would you consider FIVG to be too limited with regards to tech? The top holdings don't overlap but the sectors seem to.
Click to expand...
Not familiar with FIVG but just looked at holdings and don't see the top tech companies such as AAPL, MSFT, V, INTC, etc listed.  Granted you own these in VUG and VTI but I like being overweight tech right now so yes it seems you are underweight to me.

 
cosjobs said:
I think market goes bigly down this afternoon

40 shares TVIX aquired
Click to expand...
Kind of flat overall today, like it's not sure how to react to the Packers trading up for Love.  Shorts want to dive in huge, but possibly some decent long term value...

 
:hijacked:

was able to max my 401k/IRA/HSA for the first time last year so starting to get into individual stocks. Picked up 200 shares of CYDY at .77 and 250 of MESO at $14

Thanks to everyone posting in this thread! I have a LOT to learn but picking it up little by little I think

 
beef said:
Still holding half.  Had a sell order in than decided to wait until their 11:30 webcast today.  Guess I didn't learn from yesterday's.  What's the saying, "fool me once, DOUBLE DOWN!"  
Click to expand...
I got back in with less shares than I had though. Spot price increased again last night. 

Here are the junior U miners I am holding from all over the world which could pay off bigly if anyone cares. 

BNNLF PALAF GLATF GVXXF ENCUF AZZUF

All gleaned from people on twitter who seem to know what they’re talking about. 

I also researched Japan holding a big supply and don’t think it’s an issue. 

I am waiting on the overall market to crash again which will probably take everything down and not chancing too much. Holding a lot of cash. 

 
Covid-19 and Kidney Transplantation

April 24, 2020

https://www.nejm.org/doi/full/10.1056/NEJMc2011117

TO THE EDITOR:

Kidney-transplant recipients appear to be at particularly high risk for critical Covid-19 illness due to chronic immunosuppression and coexisting conditions.1 At Montefiore Medical Center, we identified 36 consecutive adult kidney-transplant recipients who tested positive for Covid-19 between March 16 and April 1, 2020. A total of 26 recipients (72%) were male, and the median age was 60 years (range, 32 to 77). Fourteen recipients (39%) were black, and 15 recipients (42%) were Hispanic. Twenty-seven recipients (75%) had received a deceased-donor kidney; 34 recipients (94%) had hypertension, 25 (69%) had diabetes mellitus, 13 (36%) had a history of smoking tobacco or were current smokers, and 6 (17%) had heart disease. Thirty-five of the patients (97%) were receiving tacrolimus, 34 (94%) were receiving prednisone, and 31 (86%) were receiving mycophenolate mofetil or mycophenolic acid.

The most common initial symptom was fever (in 21 patients [58%]), and diarrhea was observed in 8 patients (22%). Eight patients who were in stable condition without major respiratory symptoms (22%) were monitored at home, and 28 patients (78%) were admitted to the hospital. Twenty-seven of the hospitalized patients (96%) had radiographic findings that were consistent with viral pneumonia, and 11 (39%) received mechanical ventilation. Six patients (21%) received renal replacement therapy. At a median follow-up of 21 days (range, 14 to 28), 10 of the 36 kidney-transplant recipients (28%) and 7 of the 11 patients who were intubated (64%) had died. Two of the 8 patients who were monitored as outpatients died at home; both were recent kidney-transplant recipients who had received antithymocyte globulin within the previous 5 weeks (see the Supplementary Appendix, available with the full text of this article at NEJM.org).

Table 1 summarizes the initial laboratory results in the 28 hospitalized patients. Twenty-two (79%) were lymphopenic, 12 (43%) had thrombocytopenia, 19 (68%) had low CD3 cell counts, 20 (71%) had low CD4 cell counts, and 8 (29%) had low CD8 cell counts. Inflammatory markers were measured, and 10 patients (36%) had ferritin levels higher than 900 ng per milliliter, 13 (46%) had C-reactive protein levels higher than 5 mg per deciliter, 12 (43%) had procalcitonin levels higher than 0.2 ng per milliliter, and 16 (57%) had d-dimer levels higher than 0.5 μg per milliliter.

Although effective treatment of Covid-19 is currently unknown,2 immunosuppressive management included withdrawal of an antimetabolite in 24 of 28 patients (86%). In addition, tacrolimus was withheld in 6 of the 28 severely ill patients (21%). Hydroxychloroquine was administered to 24 of these 28 patients (86%). Apixaban was administered to patients with d-dimer levels higher than 3.0 μg per milliliter. Six severely ill patients received the CCR5 inhibitor leronlimab (PRO 140, CytoDyn) on a compassionate-use basis, and 2 received the interleukin-6 receptor antagonist tocilizumab. Interleukin-6 levels were very elevated (range, 83 to 8175 pg per milliliter) when leronlimab was initiated (on day 0) in the 5 patients with elevated interleukin-6 levels; these levels decreased markedly 3 days later (range, 37 to 2022 pg per milliliter) (see Table S2 in the Supplementary Appendix). However, only the 1 patient who had the lowest interleukin-6 level (at 83 pg per milliliter) remained in stable condition without intubation.

In conclusion, at our institution, kidney-transplant recipients with Covid-19 had less fever as an initial symptom,3 lower CD3, CD4, and CD8 cell counts,4 and more rapid clinical progression than persons with Covid-19 in the general population. The number of our patients with very low CD3, CD4, and CD8 cell counts indirectly supports the need to decrease doses of immunosuppressive agents in patients with Covid-19, especially in those who have recently received antithymocyte globulin, which decreases all T-cell subsets for many weeks. Our results show a very high early mortality among kidney-transplant recipients with Covid-19 — 28% at 3 weeks as compared with the reported 1% to 5% mortality among patients with Covid-19 in the general population who have undergone testing in the United States and the reported 8 to 15% mortality among patients with Covid-19 who are older than 70 years of age.

Enver Akalin, M.D.
Yorg Azzi, M.D.
Rachel Bartash, M.D.
Harish Seethamraju, M.D.
Michael Parides, Ph.D.
Vagish Hemmige, M.D.
Michael Ross, M.D.
Stefanie Forest, M.D., Ph.D.
Yitz D. Goldstein, M.D.
Maria Ajaimy, M.D.
Luz Liriano-Ward, M.D.
Cindy Pynadath, M.D.
Pablo Loarte-Campos, M.D.
Purna B. Nandigam, M.D.
Jay Graham, M.D.
Marie Le, M.D.
Juan Rocca, M.D.
Milan Kinkhabwala, M.D.
Montefiore Medical Center, Bronx, NY
eakalin@montefiore.org

Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.

This letter was published on April 24, 2020 at NEJM.org.

Drs. Akalin and Azzi contributed equally to this letter.
Click to expand...

 
cosjobs said:
Just saying it can happen. You usually lose, sometimes big. But I made far and away my biggest windfall ever, earlier this year. And did it in a Roth with no taxes.
Click to expand...
Not hating. Was only being half facetious. I was going to look into some options on it in all seriousness. Just to gamble a little this afternoon. But seems like volume is super thin. Guess everyone is taking a breather this afternoon. Could exacerbate a sell off but seems like people aren't as worried about holding stuff over the weekend any more.

 
NREC34 said:
I got back in with less shares than I had though. Spot price increased again last night. 

Here are the junior U miners I am holding from all over the world which could pay off bigly if anyone cares. 

BNNLF PALAF GLATF GVXXF ENCUF AZZUF

All gleaned from people on twitter who seem to know what they’re talking about. 

I also researched Japan holding a big supply and don’t think it’s an issue. 
Click to expand...
Did you read this?https://www.reuters.com/article/us-japan-nuclear-fuel-sales-exclusive/exclusive-japanese-utilities-start-selling-uranium-fuel-into-depressed-market-idUSKCN1VD0K4

A little dated, but if prices continue up, I can see Japan selling into it.  Not a huge concern like you suggest, but it's a headwind against prices going MUCH higher.   

 
sporthenry said:
Not hating. Was only being half facetious. I was going to look into some options on it in all seriousness. Just to gamble a little this afternoon. But seems like volume is super thin. Guess everyone is taking a breather this afternoon. Could exacerbate a sell off but seems like people aren't as worried about holding stuff over the weekend any more.
Click to expand...
It is like gambling, but only if you're playing trifectas and parlays.

For weekend holds, I consider what news over the weekend could make it go up (bad news) vs. go down (good news). Nowadays, I'm more likely to think there will be bad than good news, esp. on a weekend. 

 
General Malaise said:
Did you read this?https://www.reuters.com/article/us-japan-nuclear-fuel-sales-exclusive/exclusive-japanese-utilities-start-selling-uranium-fuel-into-depressed-market-idUSKCN1VD0K4

A little dated, but if prices continue up, I can see Japan selling into it.  Not a huge concern like you suggest, but it's a headwind against prices going MUCH higher.   
Click to expand...
https://twitter.com/quakes99/status/1251314851680419840?s=21

That’s the reason I’m not worried. This guy is a U expert. Japan supply is in fuel rods that can’t be easily sold elsewhere. 

 
Don't Noonan said:
Not familiar with FIVG but just looked at holdings and don't see the top tech companies such as AAPL, MSFT, V, INTC, etc listed.  Granted you own these in VUG and VTI but I like being overweight tech right now so yes it seems you are underweight to me.
Click to expand...
When did Visa become a top tech? 

FIVG tracks the Bluestar 5G Communications Index. A subset of tech. 

Don Hutson said:
CYDY is $3.00
Click to expand...
Limit purchase entered, $2.59

 
NREC34 said:
https://twitter.com/quakes99/status/1251314851680419840?s=21

That’s the reason I’m not worried. This guy is a U expert. Japan supply is in fuel rods that can’t be easily sold elsewhere. 
Click to expand...
Traders and specialists say the uranium market is likely to remain depressed for years, Reuters reported in August 2019. Australian financial services company Hartleys doesn't expect a recovery until the second half of the 2020s.

Sellers are buying and buyers are selling: Cameco and some other producers are buying on the spot market while Japanese nuclear power companies have begun offloading unwanted inventories onto the global market. The Japanese sales so far have been small, but were made at values well below the purchase price and will likely further depress the uranium market according to two senior market specialists who spoke to Reuters. "Given the extended shutdown of our reactors, we are selling uranium as well as canceling long-term contracts where necessary," Japan Atomic told Reuters.

"Japanese inventory is a big overhang in the market," a US-based market specialist said. According to Reuters' calculations, Japan's nuclear companies are sitting on nuclear fuel inventories worth nearly 50% of the market value of the nine publicly-traded nuclear utilities.

TEPCO ‒ operator of the Fukushima nuclear power plant before it was destroyed by meltdowns, fires and explosions in 2011  ‒ cancelled a supply contract with Cameco in 2017, citing force majeure in the aftermath of the Fukushima disaster. Cameco was awarded US$40.3 million in damages in July 2019 by the International Chamber of Commerce (a small fraction of the amount sought).
Click to expand...

 
@General Malaise you seem like you are pretty knowledgeable about U and other metals. Thanks. 

Someome is wrong, your article or the guy on twitter. I’m just a guy trying to hit a home run on something in this probable depression we are entering. I think U is an opportunity...

 
Intc bounced back from 5.5% down to only 1% down. Nothing huge but some gains locked up. I’m going to keep playing this market over reaction trend to goods numbers with no forward guidance

 
You must log in or register to reply here.

Similar threads

Andrew74
2025 FBG Stock Contest
2
Replies
77
Views
4K
Andrew74
Andrew74
Andrew74
2024 FBG Stock Contest
2 3
Replies
127
Views
8K
McBokonon
McBokonon
Joey Wright
2025-2026 NCAA College Basketball Thread
Replies
17
Views
416
gump
gump

Users who are viewing this thread

Total: 23 (members: 0, guests: 23)
Back
Top